COMMUNIQUÉS West-GlobeNewswire

ReWalk Personal 6.0 Exoskeleton Added to the Official German List of Medical Aids
12/06/2018
This listing enables any medically qualified individual to obtain reimbursement for a ReWalk Personal 6.0 Exoskeleton through German Statutory Health Insurance Funds, which provide coverage for 90% of the German [...]
Correction: DRAFT RESOLUTIONS of Annual General Meeting of Shareholders of joint stock company “Grindeks” to be held on 26 June 2018
12/06/2018
Details of auditor specified. 1. Reports of Board, Supervisory Council, Audit Committee and statement of Sworn auditor To take notice of the reports of the Board, the Supervisory Council, the Audit Committee and the [...]
Cynata Reports Positive Six-Month Data from Cohort A in Phase 1 Trial of CYP-001 in GvHD
12/06/2018
MELBOURNE, Australia, June 12, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX:CYP) is pleased to announce positive safety and sustained overall survival [...]
Epistem management buy-out
12/06/2018
MANCHESTER, United Kingdom, June 12, 2018 (GLOBE NEWSWIRE) -- Epistem, the Manchester UK-based Contract Research Company, announces that following investment by Foresight Group it has completed a management buy-out (“ [...]
SAP Teams with Cognoa to Bridge Gap in Healthcare for Employees Raising Young Children
12/06/2018
By incorporating Cognoa into its family benefits program, SAP empowers employees to better support their children’s developmental growth during critical early childhood years PALO ALTO, Calif., June 12, 2018 (GLOBE [...]
American College of Rheumatology Urges HHS to Adopt Drug Policy Principles that Protect Health Care Access for Chronically Ill Americans
12/06/2018
Washington, D.C., June 12, 2018 (GLOBE NEWSWIRE) -- In response to the Trump Administration’s American Patients First drug pricing blueprint, the American College of Rheumatology – which represents more than 7,700 [...]
Galectin Therapeutics Inc. Announces New CEO
12/06/2018
NORCROSS, Ga., June 12, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Harold H. Shlevin, Ph.D., currently [...]
Marrone Bio Innovations’ Amplitude™ Biofungicide is Available for This Growing Season‘s Fight Against White Mold
12/06/2018
Amplitude™ Is an Effective New Tool For Controlling White Molds In Pulse, Root And Oilseed Crops and Soil Diseases In Large Acre Crops DAVIS, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. ( [...]
Daxor Corporation Appoints Kathryn A. Kornafel Vice President of Marketing and Commercial Development
12/06/2018
NEW YORK , June 12, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) , an innovative medical instrumentation and biotechnology company focused on blood volume measurement today announces the appointment of [...]
OpGen Presents Data at ASM Microbe 2018 Demonstrating High Accuracy of Acuitas® for Predicting Antibiotic Resistance in Urine Specimens
12/06/2018
90% accuracy data presented for rapid antibiotic resistance prediction using Acuitas AMR Gene Panel and Acuitas Lighthouse on urine clinical specimens Prospective clinical trial in Colombia demonstrates 57% improvement [...]
Diffusion Pharmaceuticals Announces Validation of European Patent for Oral Formulations of TSC
12/06/2018
CHARLOTTESVILLE, Va., June 12, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the life expectancy of [...]
FDA Grants Rare Pediatric Disease Designation to A4250; Albireo Eligible to Apply for Priority Review Voucher
12/06/2018
BOSTON, June 12, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the U.S. Food and Drug [...]
Yield Endurance Strategic Partner Closes on Loan of 100 Bitcoins
12/06/2018
JERSEY CITY, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Sport Endurance, Inc.’s (OTCQB:SENZ) wholly-owned subsidiary, Yield Endurance, Inc. (“Yield”), today announced that its strategic business partner, Madison Partners [...]
Stealth Mark to Provide Automated Platform Version of ActiveDuty Intelligence System
12/06/2018
HOFFMAN ESTATES, IL, June 12, 2018 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc. (OTCQB: WCUI) today announced its wholly-owned subsidiary, StealthCo, Inc., dba Stealth Mark, has released plans to offer a specialized, [...]
Cytori Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
12/06/2018
SAN DIEGO, June 12, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq:CYTX) ("Cytori"), today provided an informational update to stockholders regarding its proposed rights offering and the expected key dates [...]
Chiesi and Holostem Announce FDA Orphan Drug Designation for GPLSCD01 for treatment of Limbal Stem Cell Deficiency (LSCD)
12/06/2018
Investigational therapy uses individual patient’s own stem cells to potentially regenerate and repair damaged eye tissue CARY, N.C., June 12, 2018 (GLOBE NEWSWIRE) -- Chiesi USA (key-A-zee) , a specialty pharmaceutical [...]
resTORbio Announces Appointment of Kerry Russell, M.D., Ph.D., as Vice President of Clinical Development
12/06/2018
Newly Created Position Strategically Expands Development Capabilities BOSTON, June 12, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC) today announced that Kerry Russell, M.D., Ph.D., has joined the company as [...]
Progressive Care Launches Opioid Alternative Treatment Campaign Aimed at Reaching Millions Affected by the Nationwide Epidemic
12/06/2018
MIAMI, June 12, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today launched a new program designed to educate patients and providers on [...]
GeneDx Announces Completion of 100,000 Exome Sequences
12/06/2018
Milestone achievement offers significant contribution to clinically relevant genetic variants used to diagnose rare and genetic diseases GAITHERSBURG, Md., June 12, 2018 (GLOBE NEWSWIRE) -- GeneDx, Inc., a subsidiary of [...]

Pages